MRL828 is a compound that combines a Tau pathology-binding ligand with a guanine group modified by ATTEC technology, allowing it to selectively target aggregated tau proteins for clearance via the autophagy-lysosome pathway (ALP). MRL828 reduces intracellular Tau aggregates and facilitates the secretion of Tau.
Formula:
C46H51FN14O5S
Target:
Microtubule Associated|||ATTECs|||Autophagy
* VAT and and shipping costs not included. Errors and price changes excepted
